Literature DB >> 21708940

Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta.

Aneta Dobierzewska1, Natalia V Giltiay, Sathish Sabapathi, Alexander A Karakashian, Mariana N Nikolova-Karakashian.   

Abstract

The IL-1β signaling cascade is initiated by the phosphorylation of IL-1β receptor-associated kinase-1 (IRAK-1), followed by its ubiquitination and degradation. This paper investigates the regulation of IRAK-1 degradation in primary hepatocytes and in HEK cells overexpressing the IL-1β receptor. We provide evidence that protein phosphatase 2A (PP2A) is a negative regulator of the phosphorylation, Lys(48)-linked ubiquitination, and degradation of IRAK-1. PP2A catalytic activity increased within 30 min of stimulation with IL-1β. siRNA against PP2A catalytic subunit (PP2Ac) or treatment with pharmacological inhibitor, okadaic acid, enhanced IRAK-1 Lys(48)-linked ubiquitination and degradation. Direct interaction between PP2Ac and IRAK-1 was observed, suggesting that IRAK-1 might be a PP2A substrate. The mechanisms of PP2A activation by IL-1β involved neutral sphingomyelinase-2 (NSMase-2) and an accumulation of ceramide. Overexpression of NSMase-2 delayed IRAK-1 degradation in a PP2A-dependent manner, whereas NSMase-2 silencing had the opposite effect. The addition of sphingomyelinase, ceramide, or a proteasome inhibitor all led to retention of IRAK-1 at the cell membrane and to increased JNK phosphorylation. This study suggests that NSMase-2- and PP2A-dependent regulation of IRAK-1 degradation is a novel mechanism to fine tune the magnitude of IL-1β response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708940      PMCID: PMC3173202          DOI: 10.1074/jbc.M111.238030

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression.

Authors:  Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

2.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Authors:  M Verheij; R Bose; X H Lin; B Yao; W D Jarvis; S Grant; M J Birrer; E Szabo; L I Zon; J M Kyriakis; A Haimovitz-Friedman; Z Fuks; R N Kolesnick
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

3.  Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.

Authors:  Taisuke Kajino; Hong Ren; Shun-Ichiro Iemura; Tohru Natsume; Bjarki Stefansson; David L Brautigan; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

4.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

5.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes.

Authors:  J Chen; M Nikolova-Karakashian; A H Merrill; E T Morgan
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

7.  Threonine 66 in the death domain of IRAK-1 is critical for interaction with signaling molecules but is not a target site for autophosphorylation.

Authors:  Detlef Neumann; Christian Kollewe; Andreas Pich; Ping Cao; Klaus Resch; Michael U Martin
Journal:  J Leukoc Biol       Date:  2008-06-04       Impact factor: 4.962

8.  Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2.

Authors:  Kristina Rutkute; Alexander A Karakashian; Natalia V Giltiay; Aneta Dobierzewska; Mariana N Nikolova-Karakashian
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.

Authors:  Norma Marchesini; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

10.  Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.

Authors:  K A Dressler; S Mathias; R N Kolesnick
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

View more
  12 in total

1.  The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation.

Authors:  Arnold Johnson; Paul H Neumann; Jianya Peng; Janey James; Vincenzo Russo; Hunter MacDonald; Nancy Gertzberg; Carlos Feleder
Journal:  J Neuroimmunol       Date:  2015-07-06       Impact factor: 3.478

Review 2.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

3.  Myeloid-Specific Gene Deletion of Protein Phosphatase 2A Magnifies MyD88- and TRIF-Dependent Inflammation following Endotoxin Challenge.

Authors:  Lei Sun; Tiffany T Pham; Timothy T Cornell; Kelli L McDonough; Walker M McHugh; Neal B Blatt; Mary K Dahmer; Thomas P Shanley
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

Review 4.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

5.  Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism.

Authors:  Aneta Dobierzewska; Lihua Shi; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

6.  Direct regulation of IGF-binding protein 1 promoter by interleukin-1β via an insulin- and FoxO-1-independent mechanism.

Authors:  L Shi; D Banerjee; A Dobierzewska; S Sathishkumar; A A Karakashian; N V Giltiay; M N Nikolova-Karakashian
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-16       Impact factor: 4.310

7.  Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle.

Authors:  Jennifer S Moylan; Jeffrey D Smith; Erin M Wolf Horrell; Julie B McLean; Gergana M Deevska; Mark R Bonnell; Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Redox Biol       Date:  2014-07-30       Impact factor: 11.799

8.  Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?

Authors:  James J DiNicolantonio; James H O'Keefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-07-28

Review 9.  The Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection.

Authors:  Fu-Chen Huang
Journal:  Int J Mol Sci       Date:  2017-08-07       Impact factor: 5.923

Review 10.  Diverse Facets of Sphingolipid Involvement in Bacterial Infections.

Authors:  Tobias C Kunz; Vera Kozjak-Pavlovic
Journal:  Front Cell Dev Biol       Date:  2019-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.